INS and Hyperglycemia: Noteworthy, the treatment with MSC-EVs did not significantly affect insulin tolerance [15, 23, 24] or ameliorate hyperglycemia [21, 25, 29], indicating that inflammation or other mechanism altered by EVs may play role, at least in this particular setting.